Skip to main content

Advertisement

SpringerLink
Log in

Regression of choroidal hemangioma following systemic paclitaxel and trastuzumab use

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H (2001) Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 108:2237–2248

    Article  CAS  PubMed  Google Scholar 

  2. Li Yim JFT, Sandinha T, Kerr JM, Ritchie D, Kemp EG (2010) Treatment review of sight threatening circumscribed choroidal hemangioma. Int J Ophthalmol 3:168–171

    Google Scholar 

  3. Challis GB, Stam HJ (1990) The spontaneous regression of cancer: a review of cases from 1900 to 1987. Acta Oncol 29:545–550

    Article  CAS  PubMed  Google Scholar 

  4. Pitta C, Bergen R, Littwin S (1979) Spontaneous regression of a choroidal hemangioma following pregnancy. Ann Ophthalmol 11:772–774

    CAS  PubMed  Google Scholar 

  5. Wang J, Lou P, Lesniewski R, Henkin J (2003) Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly. Anticancer Drugs 14:13–19

    Article  PubMed  Google Scholar 

  6. Klos KS, Zhou X, Lee S, Zhang L, Yang W, Nagata Y, Yu D (2003) Combined trastuzumab and paclitaxel treatment better inhibits erbB-2- mediated angiogenesis in breast carcinoma through a more effective inhibition of akt than either treatment alone. Cancer 98:1377–1385

    Article  CAS  PubMed  Google Scholar 

  7. Witschel H, Font RL (1976) Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol 20:415–431

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors have no conflict of interests, and no financial support from any organization.

Author information

Authors and Affiliations

  1. Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, 06100, Sihhiye, Ankara, Turkey

    Hayyam Kiratli & Salih Uzun

  2. Kozluk State Hospital, Batman, Turkey

    Berçin Tarlan

Authors
  1. Hayyam Kiratli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salih Uzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Berçin Tarlan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hayyam Kiratli.

Additional information

The authors have full control of all primary data, and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiratli, H., Uzun, S. & Tarlan, B. Regression of choroidal hemangioma following systemic paclitaxel and trastuzumab use. Graefes Arch Clin Exp Ophthalmol 252, 177–179 (2014). https://doi.org/10.1007/s00417-013-2521-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-013-2521-2

Keywords

Search

Navigation